🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ERA
$ERAS
🔒 US EquitiesErasca Inc
AVG HISTORICAL GAP
+2.65%
MAX GAP RECORD
+17.48%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ERAS
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ERAS
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 11, 2026 Earnings Release 2026-11-11 (AFTER CLOSE) | 🔮 UPCOMING 🔒 |
| Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE) |
+2.05%
|
| May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE) |
-2.11%
|
| Mar 12, 2026 Earnings Release 2026-03-12 (AFTER CLOSE) |
+3.41%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
+0.00%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
-0.64%
|
| May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE) |
+2.26%
|
| Mar 20, 2025 Earnings Release 2025-03-20 (AFTER CLOSE) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.9%
Bullish Gaps (8)
Bearish Gaps (2)
Neutral / Flat (2)
📖 Intelligence Summary
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗